Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The AAPS Journal|May 19, 2021
A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug ProductsGonçalo Farias, Jagdeep Shur, Robert Price, et al.
Pharmaceutics|November 26, 2022
Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic DevelopmentAbhinav Ram Mohan, Qiang Wang, Sneha Dhapare, et al.
International Journal of Pharmaceutics|May 28, 2017
TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulationsElizabeth Bielski, Qian Zhong, Hamad Mirza, et al.
Biochemistry|June 25, 2013
R1 motif is the major actin-binding domain of TRIOBP-4Jianjun Bao, Elizabeth Bielski, Ankita Bachhawat, et al.
Pharmaceutical Research|October 7, 2024
Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical TechniquesGonçalo Farias, William J Ganley, Robert Price, et al.
AAPS Pharmscitech|July 31, 2025
Evaluating 3D-Printed Pre-separator Inserts in a Fast Screening Impactor for Physicochemical Characterization of Fine Particle Dose Release from Dry Powder InhalersNathan A Reed, Roee Dar, Nicholas Holtgrewe, et al.
International Journal of Pharmaceutics|July 7, 2026
In situ characterization of aerosol deposition in dry powder inhalers using optical coherence tomographyTaye Tolu Mekonnen, Liam Milton-McGurk, Waiting Tai, et al.
Clinical Pharmacology and Therapeutics|January 18, 2025
A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence AssessmentsRobert Hopefl, Yuqing Gong, Elizabeth Bielski, et al.
Clinical Pharmacology and Therapeutics|February 8, 2022
Considerations for the Forced Expiratory Volume in 1 Second-Based Comparative Clinical Endpoint Bioequivalence Studies for Orally Inhaled Drug ProductsJieon Lee, Kairui Feng, Denise S Conti, et al.
Advanced Drug Delivery Reviews|August 29, 2022
Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspectiveNashwa El-Gendy, Craig M Bertha, Mohammed Abd El-Shafy, et al.
Pageof 2